Methylamines and islet function: cationic aspects.
Methylamine (2 to 10 mM) caused a dose-related inhibition of insulin release evoked in rat pancreatic islets by nutrient or non nutrient secretagogues. Trimethylamine exerted comparable effects upon insulin release. Methylamine (2 mM) inhibited insulin secretion but failed to affect 45Ca uptake and efflux in response to a rise in extracellular K+ concentration, suggesting that methylamine acts, to a certain extent at least, at a distal site in the secretory sequence. Methylamine, however, also exerted untoward ionic effects. First, methylamine (2 to 10 mM) apparently caused a dose-related increase in cellular pH. Second, methylamine (2mM) augmented 86Rb outflow from islets perifused either in the absence or presence of glucose or gliclazide, and inhibited Ca2+ inflow (as judged from the net uptake or efflux of 45Ca) in islets stimulated by D-glucose, L-leucine or 2-ketoisocaproate. This multiplicity of ionic and other effects may account for the fact that, in the presence of distinct secretagogues, the secretory process appeared more or less sensitive towards methylamine, depending on the relative importance of changes in cellular pH, K+ permeability and intracellular Ca2+ distribution as determinants of the secretory response.
D000217:Acyltransferases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005021:Ethylamines / Q000494:pharmacology; D005947:Glucose; D006863:Hydrogen-Ion Concentration; D007328:Insulin; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008744:Methylamines / Q000494:pharmacology*; D010539:Permeability; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012413:Rubidium / Q000378:metabolism; D011503:Transglutaminases
D005021:Ethylamines; D007328:Insulin; D008744:Methylamines; C027451:methylamine; D000217:Acyltransferases; D011503:Transglutaminases; D005947:Glucose; D012413:Rubidium; D011188:Potassium; D002118:Calcium; C016162:triethylamine